Back to Resource Center

Evofem Biosciences announces first patient enrolled in phase 2b/3 STI trial of Amphora ® and expects phase 3 contraceptive clinical trial data first quarter 2019

Evofem Biosciences announces first patient enrolled in phase 2b/3 STI trial of Amphora ® and expects phase 3 contraceptive clinical trial data first quarter 2019

January 2018

Click to view Press Release

Click for full info +

Full Info:


Resource Type:

Press Release

Citation:

(2018, January 23). Evofem.

Health Risks(s):

  • Chlamydia
  • Gonorrhea

Product type(s):

  • MPTs
  • VaginalCream

Topic(s):

  • MPTs
  • Development
  • Trials

      URL of resource:

      https://evofem.investorroom.com/2018-01-23-Evofem-Biosciences-Announces-First-Patient-Enrolled-in-Phase-2b-3-STI-Trial-of-Amphora-R-and-Expects-Phase-3-Contraceptive-Clinical-Trial-Data-First-Quarter-2019

      Back to Resource Center